Zoledronic acid inhibits the resorption of mineralized bone and cartilage. It inhibits the increased osteoclastic activity and skeletal calcium that is induced by stimulatory factors released by malignant tumors. Zoledronic acid is indicated for the treatment of hypercalcemia, multiple myeloma, and...